Obstetrics and Gynecology International / 2012 / Article / Tab 2

Clinical Study

Safety and Efficacy of an Intravaginal Prebiotic Gel in the Prevention of Recurrent Bacterial Vaginosis: A Randomized Double-Blind Study

Table 2

Nugent score at the different visits.

Treatment
ActivePlacebo
% %

Nugent scores at D00–3: Negative1372.221466.66
4–6: Intermediate422.22628.57
>7: Indicative of BV15.5614.77
Median, (min–max)0 (0–7)1 (0–7)
P value
(active versus placebo)
0.296

Nugent scores at D80–3: Negative18100.001466.66
4–6: Intermediate00.00628.57
>7: Indicative of BV00.0014.77
Median, (min–max)0 (0–3)1 (0–9)
P value
(active versus placebo)
0.0478

Nugent scores at D160–3: Negative18100.001676.19
4–6: Intermediate00.00419.00
>7: Indicative of BV00.0014.81
Median, (min-max)0 (0–2)0 (0–7)
P value
(active versus placebo)
0.0157

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.